VIVO Cannabis Inc (VIVO.CA) Fundamental Analysis & Valuation

TSX:VIVO • CA92845J1049

0.025 CAD
0 (0%)
Last: Apr 4, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This VIVO.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VIVO. VIVO was compared to 34 industry peers in the Pharmaceuticals industry. VIVO may be in some trouble as it scores bad on both profitability and health. VIVO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. VIVO.CA Profitability Analysis

1.1 Basic Checks

  • VIVO had negative earnings in the past year.
  • VIVO had a negative operating cash flow in the past year.
VIVO.CA Yearly Net Income VS EBIT VS OCF VS FCFVIVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -20M -40M -60M

1.2 Ratios

  • VIVO has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VIVO.CA Yearly ROA, ROE, ROICVIVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 100 200 300 400

1.3 Margins

  • VIVO has a Gross Margin of 3.71%. This is in the lower half of the industry: VIVO underperforms 60.00% of its industry peers.
  • VIVO's Gross Margin has declined in the last couple of years.
  • VIVO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.73%
GM growth 5YN/A
VIVO.CA Yearly Profit, Operating, Gross MarginsVIVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. VIVO.CA Health Analysis

2.1 Basic Checks

  • VIVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VIVO has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, VIVO has a worse debt to assets ratio.
VIVO.CA Yearly Shares OutstandingVIVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 100M 200M 300M
VIVO.CA Yearly Total Debt VS Total AssetsVIVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -6.64, we must say that VIVO is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -6.64, VIVO is not doing good in the industry: 75.56% of the companies in the same industry are doing better.
  • VIVO has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • VIVO has a better Debt to Equity ratio (0.06) than 64.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -6.64
ROIC/WACCN/A
WACC9.75%
VIVO.CA Yearly LT Debt VS Equity VS FCFVIVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 50M 100M 150M 200M

2.3 Liquidity

  • VIVO has a Current Ratio of 2.58. This indicates that VIVO is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of VIVO (2.58) is comparable to the rest of the industry.
  • A Quick Ratio of 1.17 indicates that VIVO should not have too much problems paying its short term obligations.
  • VIVO has a Quick ratio (1.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.17
VIVO.CA Yearly Current Assets VS Current LiabilitesVIVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. VIVO.CA Growth Analysis

3.1 Past

  • VIVO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -111.94%.
  • The Revenue has decreased by -2.18% in the past year.
  • The Revenue has been growing by 106.85% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-111.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.67%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y36.95%
Revenue growth 5Y106.85%
Sales Q2Q%-0.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VIVO.CA Yearly Revenue VS EstimatesVIVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 10M 20M 30M
VIVO.CA Yearly EPS VS EstimatesVIVO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

0

4. VIVO.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VIVO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VIVO.CA Price Earnings VS Forward Price EarningsVIVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VIVO.CA Per share dataVIVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VIVO.CA Dividend Analysis

5.1 Amount

  • No dividends for VIVO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

VIVO.CA Fundamentals: All Metrics, Ratios and Statistics

VIVO Cannabis Inc

TSX:VIVO (4/4/2023, 7:00:00 PM)

0.025

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A
Earnings (Next)01-06
Inst Owners0.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.27M
Revenue(TTM)25.19M
Net Income(TTM)-108.33M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.07
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.71%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.73%
GM growth 5YN/A
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.48%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 1.17
Altman-Z -6.64
F-Score2
WACC9.75%
ROIC/WACCN/A
Cap/Depr(3y)67.34%
Cap/Depr(5y)294.79%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y36.95%
Revenue growth 5Y106.85%
Sales Q2Q%-0.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.51%
OCF growth 3YN/A
OCF growth 5YN/A

VIVO Cannabis Inc / VIVO.CA FAQ

Can you provide the ChartMill fundamental rating for VIVO Cannabis Inc?

ChartMill assigns a fundamental rating of 1 / 10 to VIVO.CA.


Can you provide the valuation status for VIVO Cannabis Inc?

ChartMill assigns a valuation rating of 3 / 10 to VIVO Cannabis Inc (VIVO.CA). This can be considered as Overvalued.


How profitable is VIVO Cannabis Inc (VIVO.CA) stock?

VIVO Cannabis Inc (VIVO.CA) has a profitability rating of 0 / 10.


What is the financial health of VIVO Cannabis Inc (VIVO.CA) stock?

The financial health rating of VIVO Cannabis Inc (VIVO.CA) is 2 / 10.